Scout | Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)

This opportunity is no longer accepting applications.

grant

Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)

This grant opportunity seeks to support translational research aimed at understanding mood and psychotic disorders that worsen during menopause, such as depression, anxiety, bipolar disorder, and schizophrenia. It encourages interdisciplinary collaboration to study the neurobiological and behavioral mechanisms of these disorders during menopause. Areas of interest include the interaction betwe…

Source

Agency: National Institutes of Health

Sub-agency: National Institute of Mental Health

Program: SBIR

Dates

Opportunity Released: January 6, 2023

Open for Submission: January 6, 2023

Submission Deadline: November 5, 2024

Application Window Closes: November 5, 2024

Keywords

mood disorders

psychotic disorders

menopause transition

translational research

neurobiological mechanisms

behavioral mechanisms

treatment interventions

interdisciplinary collaboration

reproductive steroids

psychiatric symptoms

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers